These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33105146)

  • 21. The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA Trial.
    Kramer CK; Zinman B; Choi H; Connelly PW; Retnakaran R
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3702-9. PubMed ID: 26230296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term impact of chronic hemodialysis on glycemic control and serum lipids in insulin-treated type 2-diabetic patients.
    Loipl J; Schmekal B; Biesenbach G
    Ren Fail; 2005; 27(3):305-8. PubMed ID: 15957547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy.
    Jendle J; Testa MA; Martin S; Jiang H; Milicevic Z
    Diabetes Obes Metab; 2016 Oct; 18(10):999-1005. PubMed ID: 27279266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
    le Roux CW; Astrup A; Fujioka K; Greenway F; Lau DCW; Van Gaal L; Ortiz RV; Wilding JPH; Skjøth TV; Manning LS; Pi-Sunyer X;
    Lancet; 2017 Apr; 389(10077):1399-1409. PubMed ID: 28237263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the DIALYDIAB pilot study.
    Joubert M; Fourmy C; Henri P; Ficheux M; Lobbedez T; Reznik Y
    Diabetes Res Clin Pract; 2015 Mar; 107(3):348-54. PubMed ID: 25638452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
    Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D
    J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira).
    Buse JB; Vilsbøll T; Thurman J; Blevins TC; Langbakke IH; Bøttcher SG; Rodbard HW;
    Diabetes Care; 2014 Nov; 37(11):2926-33. PubMed ID: 25114296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peri-operative management of patients with type-2 diabetes mellitus undergoing non-cardiac surgery using liraglutide, glucose-insulin-potassium infusion or intravenous insulin bolus regimens: a randomised controlled trial.
    Polderman JAW; van Steen SCJ; Thiel B; Godfried MB; Houweling PL; Hollmann MW; DeVries JH; Preckel B; Hermanides J
    Anaesthesia; 2018 Mar; 73(3):332-339. PubMed ID: 29230803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial.
    Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Jensen T; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U
    Diabetes Technol Ther; 2018 Mar; 20(3):247-256. PubMed ID: 29565719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liraglutide and Renal Outcomes in Type 2 Diabetes.
    Mann JFE; Ørsted DD; Brown-Frandsen K; Marso SP; Poulter NR; Rasmussen S; Tornøe K; Zinman B; Buse JB;
    N Engl J Med; 2017 Aug; 377(9):839-848. PubMed ID: 28854085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial.
    Russell-Jones D; Vaag A; Schmitz O; Sethi BK; Lalic N; Antic S; Zdravkovic M; Ravn GM; Simó R;
    Diabetologia; 2009 Oct; 52(10):2046-55. PubMed ID: 19688338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Retrospective Continuous Glucose Monitoring for Optimizing Management of Type 2 Diabetes in India.
    Mohan V; Jain S; Kesavadev J; Chawla M; Mutha A; Viswanathan V; Saboo B; Kovil R; Mithal A; Punatar D; Shin J
    J Assoc Physicians India; 2016 Apr; 64(4):16-21. PubMed ID: 27734636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of Continuous Glucose Monitoring Metrics in Persons with Type 1 and Type 2 Diabetes Treated with Multiple Daily Insulin Injections.
    Hallström S; Hirsch IB; Ekelund M; Sofizadeh S; Albrektsson H; Dahlqvist S; Svensson AM; Lind M
    Diabetes Technol Ther; 2021 Jun; 23(6):425-433. PubMed ID: 33416422
    [No Abstract]   [Full Text] [Related]  

  • 34. The Impact of Liraglutide on Diabetes-Related Foot Ulceration and Associated Complications in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events: Results From the LEADER Trial.
    Dhatariya K; Bain SC; Buse JB; Simpson R; Tarnow L; Kaltoft MS; Stellfeld M; Tornøe K; Pratley RE;
    Diabetes Care; 2018 Oct; 41(10):2229-2235. PubMed ID: 30072400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the effect of liraglutide on glycemic variability in patients with type 2 diabetes.
    Xing Y; Chen J; Zhao L; Ma H
    Endocr J; 2020 Apr; 67(4):455-468. PubMed ID: 31996492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous glucose monitoring in an end-stage renal disease patient with diabetes receiving hemodialysis.
    Narasaki Y; Park E; You AS; Daza A; Peralta RA; Guerrero Y; Novoa A; Amin AN; Nguyen DV; Price D; Kalantar-Zadeh K; Rhee CM
    Semin Dial; 2021 Sep; 34(5):388-393. PubMed ID: 34378258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodialysis and effect of corrective measures to prevent hypoglycemia.
    Katla V; Khyalappa R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Prospective Observational Study.
    Hong S; Presswala L; Harris YT; Romao I; Ross DW; Andrade Paz H; Zhang M; Jhaveri KD; Sakhiya V; Fishbane S
    Kidney360; 2020 Sep; 1(9):897-903. PubMed ID: 35369557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous glucose monitoring in people with diabetes and end-stage kidney disease-review of association studies and Evidence-Based discussion.
    Jakubowska Z; Malyszko J
    J Nephrol; 2024 Mar; 37(2):267-279. PubMed ID: 37989976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR Assessed Changes of Renal Sinus Fat in Response to Glucose Regulation in West European and South Asian Patients With Type 2 Diabetes.
    Lin L; Dekkers IA; Tao Q; Paiman EHM; Bizino MB; Jazet IM; Lamb HJ
    J Magn Reson Imaging; 2024 Aug; 60(2):729-738. PubMed ID: 38085104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.